measured cytokines and clinical biomarkers in 51 subjects and found that peak levels of 24 cytokines (including IFN-ɣ, IL-6, sgp130, and sIL-6R) in the first month after infusion were highly associated with severe CRS. The gene discussed is IFNA1; the disease is congenital rubella syndrome.